TELESTA THERAPEUTICS INC T.TST

1/14/2016 - "Telesta's MCNA to Have Huge Presence in 2016"

[SteveMcM]

https://www.pharmpro.com/news/2016/01/trio-new-drugs-will-ignite-bladder-cancer-treatment-market-2017

January 14th, 2016

"The bladder cancer treatment market is set to boom from an estimated $177.1 million in 2015 to over $646.6 million in 2017, as the launch of three new therapies over the next two years revitalizes a largely stagnant arena, according to research and consulting firm GlobalData.

The company’s latest report* states that the growth, which will occur across the 6 Major Markets (6MM) of the US, France, Germany, Italy, Spain and the UK, will be primarily down to the introduction of Telesta Therapeutics’ MCNA and Roche’s atezolizumab in 2016 and Bristol-Myers Squibb’s Opdivoin 2017."

[ragingbull1234]

Poor Opdivoin.   I wonder if it's been ready since 2006?

[rgonlyfactspls]

Hugely interesting and supportive!!... And, important to see this report was published "after" MCNA's AdCom outcome/results so AdCom event included in deriving forecast/approval likelihood (published December-15). Lots of time to factor-in MCNA AdCom results and make a judgement call on MCNA's near-term/longer-term outlook. Steve McM...Thanks for taking the time to find and share